These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 26676034)

  • 1. Identification, Purification, and Characterization of Staphylococcal Superantigens.
    Merriman JA; Schlievert PM
    Methods Mol Biol; 2016; 1396():19-33. PubMed ID: 26676034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of IgE and IgG1 in human B cell cultures with staphylococcal superantigens: role of helper T cell interaction, resistance to interferon-gamma.
    Armerding D; van Reijsen FC; Hren A; Mudde GC
    Immunobiology; 1993 Jul; 188(3):259-73. PubMed ID: 7693580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation.
    Arad G; Levy R; Hillman D; Kaempfer R
    Nat Med; 2000 Apr; 6(4):414-21. PubMed ID: 10742148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rabbit Model for Superantigen-Mediated Lethal Pulmonary Disease.
    Strandberg KL; Rotschafer JH; Schlievert PM
    Methods Mol Biol; 2016; 1396():81-93. PubMed ID: 26676039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of bacterial superantigens by peptides and antibodies.
    Visvanathan K; Charles A; Bannan J; Pugach P; Kashfi K; Zabriskie JB
    Infect Immun; 2001 Feb; 69(2):875-84. PubMed ID: 11159981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mini-Osmotic Pump Infusion Model to Investigate the Systemic Effects of Chronic Continuous Exposure to Staphylococcal Superantigen in Mice.
    Krogman AL; Chowdhary V; Rajagopalan G
    Methods Mol Biol; 2016; 1396():109-114. PubMed ID: 26676041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human antibodies to bacterial superantigens and their ability to inhibit T-cell activation and lethality.
    LeClaire RD; Bavari S
    Antimicrob Agents Chemother; 2001 Feb; 45(2):460-3. PubMed ID: 11158741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell superantigens: definition and potential impact on the immune response.
    Levinson AI; Kozlowski L; Zheng Y; Wheatley L
    J Clin Immunol; 1995 Nov; 15(6 Suppl):26S-36S. PubMed ID: 8613489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A kinetic comparative study on lymphocyte responses to superantigen and phytohemagglutinin: reciprocal presentation of superantigen on the surface of activated lymphocytes.
    Ijichi S; Yamano Y; Osame M; Hall WW
    Cell Immunol; 1996 Nov; 173(2):312-6. PubMed ID: 8912892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Human Regulatory T Cells with Bacterial Superantigens.
    Caserta S; Taylor AL; Terrazzini N; Llewelyn MJ
    Methods Mol Biol; 2016; 1396():181-206. PubMed ID: 26676048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of staphylococcal enterotoxin-like toxin type R.
    Omoe K; Imanishi K; Hu DL; Kato H; Takahashi-Omoe H; Nakane A; Uchiyama T; Shinagawa K
    Infect Immun; 2004 Jun; 72(6):3664-7. PubMed ID: 15155681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of Recombinant Single Chain Variable Fragment (ScFv) Antibody Against Superantigen for Immunodetection Using Antibody Phage Display Technology.
    Singh PK; Agrawal R; Kamboj DV; Singh L
    Methods Mol Biol; 2016; 1396():207-225. PubMed ID: 26676049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcal superantigens induce lymphotactin production by human CD4+ and CD8+ T cells.
    Tikhonov I; Kitabwalla M; Wallace M; Malkovsky M; Volkman B; Pauza CD
    Cytokine; 2001 Oct; 16(2):73-8. PubMed ID: 11683588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppression by T regulatory cells in cows infected with Staphylococcal superantigen.
    Chang BS; Bohach GA; Lee SU; Davis WC; Fox LK; Ferens WA; Seo KS; Koo HC; Kwon NH; Park YH
    J Vet Sci; 2005 Sep; 6(3):247-50. PubMed ID: 16131830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dual phases of the response to neonatal exposure to a VH family-restricted staphylococcal B cell superantigen.
    Silverman GJ; Nayak JV; Warnatz K; Hajjar FF; Cary S; Tighe H; Curtiss VE
    J Immunol; 1998 Nov; 161(10):5720-32. PubMed ID: 9820554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the TCR alpha-chain to the differential recognition of bacterial and retroviral superantigens.
    Daly K; Nguyen P; Hankley D; Zhang WJ; Woodland DL; Blackman MA
    J Immunol; 1995 Jul; 155(1):27-34. PubMed ID: 7602104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Staphylococcal superantigens and chronic inflammation of nasal mucosa].
    Dong Z; She CP
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Mar; 40(3):233-5. PubMed ID: 15952585
    [No Abstract]   [Full Text] [Related]  

  • 18. [Superantigens and their importance for inflammatory skin diseases].
    Olsen JV; Skov L; Baadsgaard O
    Ugeskr Laeger; 1999 Aug; 161(34):4747-50. PubMed ID: 10500463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the possible relationship between staphylococcal superantigens and increased Vbeta5.1 usage in cutaneous T-cell lymphoma.
    Vonderheid EC; Bigler RD; Hou JS
    Br J Dermatol; 2005 Apr; 152(4):825-6; author reply 827. PubMed ID: 15840139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.